NeuRx DPS, the world leading diaphragm pacing device, helping hundreds of pateints move away from mechanical ventilation, has been...

The American College of Surgeons have issued their guidelines for Spine Surgery in March 2022, The guidelines recommends the...

Using the same technology of diaphragm pacing as its predecessor, and the flagship of Synapse Biomedical Inc®. NeuRx DPS, FDA has granted...

Diaphragm Pacing can Enhance Recovery and Weaning from Mechanical Ventilation (MV) in Cardiac Surgery In a press release published on...

Prof. Raymond Onders, Remen Chair of Surgical innovation in Case Western Reserve University School of Medicine, gives a Webinar about the...

News of FDA approval of Synapse Biomedical Inc. FDA approval of TransAeris, its temporary diaphragm pacing device, is circulating in...

Patients who undergo major chest and abdominal surgeries that are critically ill have a high tendency for suffering from difficulties in...

The NeuRx® Diaphragm Pacing System is designed as an alternative treatment for patients with spinal cord injuries that result in the...